Abstract: Protein gene product 9.5 (PGP9.5) is expressed at high level in the neural and neuroendocrine systems. We investigated the localization and degree of expression of PGP9.5 in the developing mouse placenta and embryo at 6.5, 10.5 and 14 days of gestation using an immunohistochemical technique. At 6.5 days of gestation PGP9.5 was detected at various levels in decidual and primary trophoblast giant cells in the placenta, and in embryonic ectodermal cells in the embryo. At 10.5 and 14 days of gestation PGP9.5 was expressed at moderate to strong levels in neurons in the embryo, but rarely in the placenta. These findings suggest that the protein may play a significant role in implantation and placental development, and differentiation of embryonic ectoderm.
lent to ubiquitin carboxyl-terminal hydrolase isozyme L1 (UCHL1) [21] . PGP9.5 is one of the major proteins in the brain, constituting 1 to 5% of total soluble brain proteins [21] . Neuroaxonal dystrophy in the gracile nucleus of the medulla and gracile fascicules of the spinal cord occurs in the gracile axonal dystrophy (Gad) mouse due to deficiency of UCHL1 [13, 23] . The Gad mouse also exhibits deterioration of spermatogenesis with aging because PGP9.5/UCHL1 expression is defective in the spermatogonia and Sertoli cells [9] .
The ubiquitin-proteasome system is a major pathway for selective protein degradation [4] . Ubiquitin attaches to the target proteins and forms a polyubiquitin chain, and the ubiquitinated proteins are recognized and degraded by a multi-subunit protease complex, called the proteasome [1] . Ubiquitin carboxyl-terminal hydrolases recycle ubiquitin from ubiquitin/protein complexes or polyubiquitin chains by cleaving the amide linkage neighbouring the C-terminal glycine of ubiquitin [19, 20] . The protein gene product 9.5 (PGP9.5) is equiva- Immunohistochemical studies have demonstrated that PGP9.5 is highly expressed in neuronal and neuroendocrine tissues [3, 6, 10, 15, 24, 25] , and PGP9.5 has also been shown to be expressed in the distal tubular epithelial cells, ova and corpus luteum cells of the ovary, Leydig cells and Sertoli cells of the testis of the mouse [8, 22] , synoviocytes in the joints of the horse [7] , and hair follicle cells of the rat [11] . Localization of PGP9.5 in the mouse embryo has also been described [6, 14] . PGP9.5 is present at high levels in the neuronal tissues in mouse embryo after 10.5 days of gestation [19] , and in rat embryos after 11.5 days of gestation [6] . Though the presence of this protein has been revealed in the embryo, little is known about the placenta. The placenta fulfills indispensable functions such as metabolism, and provides an immunological barrier and endocrine secretion for embryonic development. In this paper we examined the localization and degree of the expression of PGP9.5 in the mouse placenta and embryo during the period of pregnancy. C57BL/6J mice of both sexes were allowed to mate and midday when a vaginal plug was recognized was considered as day 0.5 of gestation. Two female mice at 6.5, 10.5 and 14 days of gestation, respectively, were sacrificed by cervical dislocation under ether anesthetization. Embryos and whole uterus were fixed in Bouin's solution for 5 to 6 h, then embedded in paraffin. Paraffin sections were cut at 5 to 6 µm in thickness, deparaffinized in xylene, and stained with haematoxylin and eosin.
Immunostaining was carried out by a labeled streptavidin-biotin (LsAB) method using rabbit antihuman PGP9.5 polyclonal antibody (Ultraclone Ltd. U.K.) as a primary antibody. Deparaffinized sections were pretreated with 0.3% H 2 O 2 in methanol for 30 min and washed in phosphate buffer saline (PBS). In order to enhance immunoreactivity, sections were subjected to autoclave treatment for 10 min at 121°C. Non-specific binding of immunogloblins was blocked by incubation with Block Ace (Dainippon pharamaceutical Ltd. Japan) for 1 h at room temperature. After blocking, sections were incubated with primary antibody diluted at 1 : 8000 for 16 h at 4°C. Next, sections were incubated with biotinylated goat anti-rabbit IgG (DAKO Ltd. Denmark) diluted at 1 : 500 for 30 min at 37°C, and after washing in PBS, they were reacted with horseradish peroxidase conjugated streptavidin (DAKO Ltd. Denmark) diluted at 1 : 500 for 30 min at room temperature. After washing in PBS, the immunoreaction was visualized by incubation in 3,3'-diaminobenzidine tetrahydrochloride (DAB)
The immunoreactivity of PGP9.5 was detected at various levels in decidual cells around the embryo and in primary trophoblastic giant cells at 6.5 days of gestation (Fig. 1a) . The moderately or strongly positive decidual cells showed not only cytoplasmic but also nuclear staining. At 10.5 days of gestation, decidual cells with various levels of staining were seen in the smaller area of the basal decidua, and they also showed nuclear staining (Fig. 1b) . At 14 days of gestation, a few cells stained positive at weak to moderate levels were present in the basal decidua (Fig. 1c , Table1) . There was no difference in immunoreactivity of PGP9.5 among mouse placentas of the same litter mates.
At 6.5 days of gestation, moderate PGP9.5 immunoreactivity was detected in embryonic ectodermal cells (Fig. 1a) . At 10.5 days of gestation, most neural tubular cells and intestinal epithelial cells were immunopositive at a moderate grade (Fig. 1d) . In addition, otic vesicular cells, epithelial cells of the Wolffian duct, and notocord cells were weakly immunopositive. At 14 days of gestation, most of neurons were moderately or strongly positive. The neurons of the peripheral (Fig. 1e) , ganglions (Fig. 1f) , migrated mature neurons of the mesencephalon (Fig. 1g) , and sensory epithelial cells of the retina and semicircular canals (Fig. 1f) were especially strongly stained. These strongly immunopositive cells also showed nuclear staining. Moreover, gonocytes of testis (Fig. 1h) were weakly or moderately stained, and a weak, positive reaction was seen in ependymocytes, adenohypophysis cells, epithelial cells of nasal pit, bronchi, mesonephric duct, mesonephric tubule, paramesonephric duct, ureter, hair follicle and some chondroblasts ( Table 2) . PGP9.5 expression in the embryo changed with embryogenesis, however, there was no difference in the immunoreactivity of PGP9.5 of mouse embryos among the same litter mates. This study showed that PGP9.5 was expressed at various levels in decidual cells from the early stage of pregnancy, while the number of PGP9.5 positive cells decreased in the late stage. Generally, after implantation, the area occupied by decidual cells increases from 6 days to 10 days of gestation, and thereafter slightly decreases in the mouse [5] . The structure of the mouse placenta was unchanged after 14 days of gestation [17] , and its weight and the number of the constituent cells reached a plateau by 14 days of gestation [5] . In fact, the decidual cells expressing PGP9.5 appeared and increased immediately after implantation, and thereafter most of them had disappeared by the time the placenta matured.
At 6.5 days primary trophoblastic giant cells were immunopositive at low to moderate levels, whereas at 10.5 and 14 days trophoblastic giant cells were all negative. Primary trophoblastic giant cells are derived from embryonal trophoblast and invade the maternal tissue on implantation [17] . This early expression of PGP9.5 in decidual and primary trophoblastic giant cells and the subsequent decreasing number of the positive cells suggest that the protein may play a significant role in implantation and placenta development Decidual cells are thought to function as a barrier to prevent immune rejection between the maternal body and embryo [18] . Therefore, they might degrade immunoproteins which are disadvantageous for embryo development.
In the embryo of the pregnant mouse PGP9.5 was already been expressed at a moderate level in embryonic ectodermal cells at 6.5 days of gestation, and the protein was expressed at moderate to strong levels in mature neurons at 10.5 and 14 days of gestation. The nerves develop from the embryonic ectoderm [12] . This means that the protein plays an important role in degradation of unnecessary proteins in the process of embryonic ectodermal differentiation. Mature neurons expressed the protein more strongly than immature ones; therefore, we assume that the more neurons mature, the more active their metabolism becomes. This assumption is supported by the immunostaning of PGP9.5 in the nucleus as well as the cytoplasm in mature neurons. At 10.5 days and 14 days of gestation PGP9.5 was demonstrated at low to moderate leves in the endodermal and mesodermal tissues, such as testis and bronchi. Although the distribution of PGP9.5 mRNA in developing gonads in the mouse was reported by Schofield et al. [14] , this is the first description of the expression of PGP9.5 protein in the developing mouse embryo. The distribution of the protein in the developing lung was reported in human and rat [2, 16] . The significance of the expressions of PGP9.5 in the developing embryo remains unclear.
